These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11393590)

  • 21. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.
    Yang Z; Arnet U; Bauer E; von Segesser L; Siebenmann R; Turina M; Lüscher TF
    Circulation; 1994 May; 89(5):2266-72. PubMed ID: 8181152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.
    Mikhailidis DP; Jeremy JY; Barradas MA; Green N; Dandona P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1495-8. PubMed ID: 6416473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of extracts from garden radish (Raphanus sativus) and horseradish (Amoracia rusticana) on platelet functional activity in vitro.
    Kasjanovová D; Macejka J
    Pharmazie; 1992 Nov; 47(11):876-7. PubMed ID: 1492118
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of recombinant-tissue plasminogen activator, low molecular weight urokinase and unfractionated heparin on platelet aggregation.
    Paolini R; Casonato A; Boeri G; Luzzatto G; Girolami A; Sasahara AA; Cella G
    J Med; 1993; 24(2-3):113-30. PubMed ID: 8409776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Burzacca S; Mattiello L; Trovati M
    Gen Pharmacol; 1991; 22(5):773-8. PubMed ID: 1684769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of H2-receptor antagonists on platelet function in vitro.
    Nakamura K; Kariyazono H; Shinkawa T; Yamaguchi T; Yamashita T; Ayukawa O; Moriyama Y; Yotsumoto G; Toyohira H; Taira A; Yamada K
    Hum Exp Toxicol; 1999 Aug; 18(8):487-92. PubMed ID: 10462360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelium and platelet preparations for the prediction of xenobiotic effects on the vascular system.
    Togna G; Togna AR; Caprino L
    Xenobiotica; 1985; 15(8-9):661-4. PubMed ID: 3934852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of prostacyclin/thromboxane formation by molsidomine during platelet-endothelial cell interactions.
    Bordet JC; Lagarde M
    Biochem Pharmacol; 1988 Oct; 37(20):3911-4. PubMed ID: 3142481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic isoxazole as antiplatelet agent.
    Gutiérrez M; Amigo J; Fuentes E; Palomo I; Astudillo L
    Platelets; 2014; 25(4):234-8. PubMed ID: 23841686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase.
    Ye J; Zhai L; Zhang S; Zhang Y; Chen L; Hu L; Zhang S; Ding Z
    Platelets; 2015; 26(8):736-44. PubMed ID: 25734213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
    Lin CH; Kuo YH; Lin YL; Teng CM
    J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation.
    Yamada Y; Furui H; Furumichi T; Suzuki T; Yamauchi K; Yokota M; Hayashi H; Saito H
    Jpn Heart J; 1990 Mar; 31(2):201-15. PubMed ID: 2113109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in platelet reactivity and response to low-dose aspirin therapy.
    Becker DM; Segal J; Vaidya D; Yanek LR; Herrera-Galeano JE; Bray PF; Moy TF; Becker LC; Faraday N
    JAMA; 2006 Mar; 295(12):1420-7. PubMed ID: 16551714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro effect of reduced glutathione on platelet function.
    Pacchiarini L; Tua A; Grignani G
    Haematologica; 1996; 81(6):497-502. PubMed ID: 9009436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased platelet activity after termination of prostacyclin infusion into man.
    Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
    Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.